Gartner, Inc. Right-of-Use Asset Obtained in Exchange for Operating Lease Liability
Gartner, Inc. (IT) reported Right-of-Use Asset Obtained in Exchange for Operating Lease Liability of $1.82 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Notes › Leases
us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability · last filed 2026-08-04
- Gartner, Inc. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2026-06-30 was $1.82M, a 81.92% decline year-over-year.
- Gartner, Inc. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2026-03-31 was $25.88M, a 410.37% increase year-over-year.
- Gartner, Inc. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2025-12-31 was $1.80M, a 88.10% decline year-over-year.
- Gartner, Inc. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2025-09-30 was $5.74M, a 136.64% increase year-over-year.
- Gartner, Inc. right-of-use asset obtained in exchange for operating lease liability for fiscal 2025 was $22.66M, a 19.90% decline from fiscal 2024.
- Gartner, Inc. right-of-use asset obtained in exchange for operating lease liability for fiscal 2024 was $28.29M, a 122.50% increase from fiscal 2023.
- Gartner, Inc. right-of-use asset obtained in exchange for operating lease liability for fiscal 2023 was $12.71M, a 38.27% decline from fiscal 2022.
- Gartner, Inc. right-of-use asset obtained in exchange for operating lease liability for fiscal 2022 was $20.60M, a 37.80% decline from fiscal 2021.
| Period end | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 3 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 6 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 9 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.82M 10-Q · filed 2026-08-04 | $27.70M 10-Q · filed 2026-08-04 | $29.50M derived: sum of 3 quarters · filed 2026-08-04 | $35.24M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $25.88M 10-Q · filed 2026-05-05 | $27.68M derived: sum of 2 quarters · filed 2026-05-05 | $33.42M derived: sum of 3 quarters · filed 2026-05-05 | $43.47M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $1.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $7.54M derived: sum of 2 quarters · filed 2026-02-12 | $17.59M derived: sum of 3 quarters · filed 2026-08-04 | $22.66M 10-K · filed 2026-02-12 |
| 2025-09-30 | $5.74M 10-Q · filed 2025-11-04 | $15.79M derived: sum of 2 quarters · filed 2026-08-04 | $20.86M 10-Q · filed 2025-11-04 | $35.99M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $10.05M 10-Q · filed 2026-08-04 | $15.12M 10-Q · filed 2026-08-04 | $30.25M derived: sum of 3 quarters · filed 2026-08-04 | $32.67M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $5.07M 10-Q · filed 2026-05-05 | $20.20M derived: sum of 2 quarters · filed 2026-05-05 | $22.63M derived: sum of 3 quarters · filed 2026-05-05 | $26.57M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $15.13M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $17.56M derived: sum of 2 quarters · filed 2026-02-12 | $21.50M derived: sum of 3 quarters · filed 2026-02-12 | $28.29M 10-K · filed 2026-02-12 |
| 2024-09-30 | $2.43M 10-Q · filed 2025-11-04 | $6.37M derived: sum of 2 quarters · filed 2025-11-04 | $13.16M 10-Q · filed 2025-11-04 | $16.41M derived: sum of 4 quarters · filed 2026-02-12 |
| 2024-06-30 | $3.94M 10-Q · filed 2025-08-05 | $10.73M 10-Q · filed 2025-08-05 | $13.98M derived: sum of 3 quarters · filed 2026-02-12 | $15.46M derived: sum of 4 quarters · filed 2026-02-12 |
| 2024-03-31 | $6.79M 10-Q · filed 2025-05-06 | $10.04M derived: sum of 2 quarters · filed 2026-02-12 | $11.52M derived: sum of 3 quarters · filed 2026-02-12 | $17.86M derived: sum of 4 quarters · filed 2026-02-12 |
| 2023-12-31 | $3.25M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $4.72M derived: sum of 2 quarters · filed 2026-02-12 | $11.07M derived: sum of 3 quarters · filed 2026-02-12 | $12.71M 10-K · filed 2026-02-12 |
| 2023-09-30 | $1.48M 10-Q · filed 2024-11-05 | $7.82M derived: sum of 2 quarters · filed 2024-11-05 | $9.47M 10-Q · filed 2024-11-05 | $10.94M derived: sum of 4 quarters · filed 2025-02-13 |
| 2023-06-30 | $6.34M 10-Q · filed 2024-07-30 | $7.99M 10-Q · filed 2024-07-30 | $9.47M derived: sum of 3 quarters · filed 2025-02-13 | $16.91M derived: sum of 4 quarters · filed 2025-02-13 |
| 2023-03-31 | $1.65M 10-Q · filed 2024-04-30 | $3.12M derived: sum of 2 quarters · filed 2025-02-13 | $10.56M derived: sum of 3 quarters · filed 2025-02-13 | $15.31M derived: sum of 4 quarters · filed 2025-02-13 |
| 2022-12-31 | $1.48M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13 | $8.91M derived: sum of 2 quarters · filed 2025-02-13 | $13.67M derived: sum of 3 quarters · filed 2025-02-13 | $20.60M 10-K · filed 2025-02-13 |
| 2022-09-30 | $7.44M 10-Q · filed 2023-11-03 | $12.19M derived: sum of 2 quarters · filed 2023-11-03 | $19.12M 10-Q · filed 2023-11-03 | $24.15M derived: sum of 4 quarters · filed 2024-02-15 |
| 2022-06-30 | $4.75M 10-Q · filed 2023-08-01 | $11.68M 10-Q · filed 2023-08-01 | $16.71M derived: sum of 3 quarters · filed 2024-02-15 | $35.50M derived: sum of 4 quarters · filed 2024-02-15 |
| 2022-03-31 | $6.93M 10-Q · filed 2023-05-02 | $11.96M derived: sum of 2 quarters · filed 2024-02-15 | $30.75M derived: sum of 3 quarters · filed 2024-02-15 | $33.00M derived: sum of 4 quarters · filed 2024-02-15 |
| 2021-12-31 | $5.03M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-15 | $23.82M derived: sum of 2 quarters · filed 2024-02-15 | $26.07M derived: sum of 3 quarters · filed 2024-02-15 | $33.11M 10-K · filed 2024-02-15 |
| 2021-09-30 | $18.79M 10-Q · filed 2022-11-01 | $21.04M derived: sum of 2 quarters · filed 2022-11-01 | $28.08M 10-Q · filed 2022-11-01 | $36.28M derived: sum of 4 quarters · filed 2023-02-16 |
| 2021-06-30 | $2.25M 10-Q · filed 2022-08-02 | $9.29M 10-Q · filed 2022-08-02 | $17.49M derived: sum of 3 quarters · filed 2023-02-16 | $18.02M derived: sum of 4 quarters · filed 2023-02-16 |
| 2021-03-31 | $7.05M 10-Q · filed 2022-05-03 | $15.24M derived: sum of 2 quarters · filed 2023-02-16 | $15.77M derived: sum of 3 quarters · filed 2023-02-16 | $19.39M derived: sum of 4 quarters · filed 2023-02-16 |
| 2020-12-31 | $8.20M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-16 | $8.72M derived: sum of 2 quarters · filed 2023-02-16 | $12.34M derived: sum of 3 quarters · filed 2023-02-16 | $27.26M 10-K · filed 2023-02-16 |
| 2020-09-30 | $527.00K 10-Q · filed 2021-11-02 | $4.14M derived: sum of 2 quarters · filed 2021-11-02 | $19.06M 10-Q · filed 2021-11-02 | $88.30M derived: sum of 4 quarters · filed 2022-02-23 |
| 2020-06-30 | $3.62M 10-Q · filed 2021-08-03 | $18.54M 10-Q · filed 2021-08-03 | $87.78M derived: sum of 3 quarters · filed 2022-02-23 | $126.35M derived: sum of 4 quarters · filed 2022-02-23 |
| 2020-03-31 | $14.92M 10-Q · filed 2021-05-04 | $84.16M derived: sum of 2 quarters · filed 2022-02-23 | $122.73M derived: sum of 3 quarters · filed 2022-02-23 | $150.53M derived: sum of 4 quarters · filed 2022-02-23 |
| 2019-12-31 | $69.24M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-23 | $107.81M derived: sum of 2 quarters · filed 2022-02-23 | $135.61M derived: sum of 3 quarters · filed 2022-02-23 | $137.00M 10-K · filed 2022-02-23 |
| 2019-09-30 | $38.57M 10-Q · filed 2020-11-03 | $66.37M derived: sum of 2 quarters · filed 2020-11-03 | $67.76M 10-Q · filed 2020-11-03 | |
| 2019-06-30 | $27.80M 10-Q · filed 2019-07-30 | $29.18M 10-Q · filed 2019-07-30 | ||
| 2019-03-31 | $1.39M 10-Q · filed 2019-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Evolent Health, Inc. (EVH) | United States | $0.397B | -1.21 |
| FRANKLIN COVEY CO (FC) | United States | $0.195B | 123.76 |